Pharming Group

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Pharming Group and other ETFs, options, and stocks.

About PHAR

Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. 

CEO
Sijmen de Vries
CEOSijmen de Vries
Employees
Employees
Headquarters
Leiden, Zuid-Holland
HeadquartersLeiden, Zuid-Holland
Founded
1988
Founded1988
Employees
Employees

PHAR Key Statistics

Market cap
825.00M
Market cap825.00M
Price-Earnings ratio
26.42
Price-Earnings ratio26.42
Dividend yield
Dividend yield
Average volume
6.36K
Average volume6.36K
High today
$13.25
High today$13.25
Low today
$11.76
Low today$11.76
Open price
$12.35
Open price$12.35
Volume
4.64K
Volume4.64K
52 Week high
$13.25
52 Week high$13.25
52 Week low
$6.10
52 Week low$6.10

PHAR Earnings

-$0.00
$0.01
$0.01
$0.02
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Mar 16, Pre-Market
ActualExpected Mar 16, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.